Actualizado 19/10/2012 18:16
- Comunicado -

Mirabegron Receives Positive CHMP Opinion for Treatment of Overactive Bladder Symptoms (y 2)

CONTACT: For further information please contact: Julia Holt, Red DoorCommunications, jholt@rdcomms.com , Tel: +44(0)20-8392-8052, Mobile:+44(0)7788-441422; Mindy Dooa, Astellas Pharma Europe Ltd.,Mindy.Dooa@astellas.com , Tel: +44(0)203-379-8035, Mobile:+44(0)7826-912-339